Parabolic Drugs (Delisted) share price history
BSE: 533211Pharmaceuticals & Biotechnology
Last traded ₹5.50 on 25 Jan 2021
Delisted on 11 Aug 2021.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Aug 2021
4 Aug · Voluntary Delisting
Members of the Exchange are hereby informed that the admission to dealings in securities of Parabolic Drugs Limited shall be withdrawn (delisted) w.e.f. August 11, 2021 Pursuant to Resolution plan Approved by Hon'ble National Company Law Tribunal (NCLT) Under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016."
Feb 2021
8 Feb · Corporate Insolvency Resolution Process
8 Feb · Corporate Insolvency Resolution Process (CIRP)-Public Announcement
Results
Standalone, as consolidated accounts are on record for only 3 of the last ten years; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Mar 2020Filed 25 Aug
- Revenue
- ₹0.00 Cr
- Net profit
- −₹7.22 Cr
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Sep 2018Filed 23 Nov | Dec 2018Filed 18 Feb | Mar 2019Filed 25 Aug | Jun 2019Filed 19 Aug | Sep 2019 | Dec 2019 | Mar 2020Filed 25 Aug | Jun 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.0 | 0.3 | 0.0 | 0.0 | – | – | 0.0 | – |
| Net profit | −14.3 | −7.1 | −8.3 | −7.8 | – | – | −7.2 | – |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −288.5% | −2,726.9% | – | – | – | – | – | – |
Business segments
In the year to Mar 2020 the company reports one business segment, PHARMACEUTICALS, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2020, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −28.1% | – | – | 0.0% |
| 3 years | −48.7% | – | – | 0.0% |
| 5 years | −33.4% | – | – | 0.0% |
Parabolic Drugs share price by year
Each calendar year to 2021.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2021 | 5.50 | +8.9% | 6.35 | 5.30 |
| 2020 | 5.05 | +68.3% | 5.05 | 0.70 |
| 2019BSE close | 3.00 | +15.4% | 3.90 | 0.50 |
| 2018 | 2.60 | −69.4% | 8.95 | 2.50 |
| 2017 | 8.50 | +6.3% | 11.35 | 6.10 |
| 2016 | 8.00 | −13.0% | 10.90 | 3.85 |
| 2015 | 9.20 | +4.0% | 15.00 | 7.05 |
Recent sessions
The last 10 trading days to 25 Jan 2021, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 25 Jan 2021 | 5.50 | 5.50 | 5.50 | 5.50 | 5.50 | 123 |
| 18 Jan 2021 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 48,033 |
| 8 Jan 2021 | 6.65 | 6.65 | 6.05 | 6.05 | 6.44 | 1,31,992 |
| 7 Jan 2021 | 6.35 | 6.35 | 6.35 | 6.35 | 6.35 | 10,098 |
| 6 Jan 2021 | 6.05 | 6.05 | 6.05 | 6.05 | 6.05 | 8,339 |
| 5 Jan 2021 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 60,912 |
| 4 Jan 2021 | 5.55 | 5.55 | 5.55 | 5.55 | 5.55 | 22,364 |
| 1 Jan 2021 | 5.30 | 5.30 | 5.30 | 5.30 | 5.30 | 8,665 |
| 31 Dec 2020 | 5.05 | 5.05 | 5.05 | 5.05 | 5.05 | 4,403 |
| 30 Dec 2020 | 4.85 | 4.85 | 4.85 | 4.85 | 4.85 | 14,651 |
Company details
- Legal name
- Parabolic Drugs Ltd
- BSE code
- 533211
- ISIN
- INE618H01016
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Jul 2010
- Face value
- ₹10
- Former symbols
- PARABDRUGS
- CIN
- L24231CH1996PLC017755
- Corporate identity number, the registrar of companies' code for it